News

Bangladesh Faces COVID-19 Vaccine Shortage Amid Surge in New Omicron Sub-Variants

Bangladesh is grappling with a shortage of COVID-19 vaccines just as new sub-variants of the Omicron strain begin to spread rapidly across the country.

Dhaka: Bangladesh is grappling with a shortage of COVID-19 vaccines just as new sub-variants of the Omicron strain begin to spread rapidly across the country. The Directorate General of Health Services (DGHS) has revealed that only 3.2 million doses of older vaccines remain in stock — many of which are set to expire in the coming months

COVID-19 Infection Rate Rises Sharply in May

Data from the Institute of Epidemiology, Disease Control and Research (IEDCR) in Dhaka shows a worrying spike in infections. In May 2025, 134 out of 1,409 samples tested positive, indicating an infection rate of 9.51% — the highest monthly figure recorded between January and May.

Also Read: Air India Cancels 8 Flights, Including 4 International Routes

Procurement of New Vaccines Still Underway

Officials confirmed that no new vaccines targeting the latest Omicron sub-variants have arrived yet. However, procurement efforts are in progress.

Public Hesitancy Fuelled by Misinformation

Despite the surge in cases, health officials noted a lack of public interest in getting vaccinated. According to Rashid, rumors and misinformation — often without scientific basis — have contributed to the public’s hesitancy.

New Cases and Fatalities Reported

As of Thursday morning, 28 new COVID-19 cases were reported, bringing the country’s total confirmed cases to 2,051,932. The first COVID-related death in Bangladesh for 2025 occurred on June 5, when a man died in Dhaka.

So far, the total death toll from the virus in Bangladesh has surpassed 29,500 since the start of the pandemic.

Health Experts Call for Immediate Preparedness

Medical experts warn that early preparedness is crucial to containing the spread of new COVID-19 variants. They stress that proactive vaccination efforts, awareness campaigns, and early policy measures can significantly reduce both infection rates and potential fatalities.

Back to top button